http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0882699-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44c713790ce00813da2e6c6d57a29456 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9822bceff022feda91b10019125e70f |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-12 |
| filingDate | 1997-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36a6afd445a713fc266f707607ced77f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51ec10a0bc419a1aa901a8bad4e4b5b6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df9fc0f8f0da875ce0db5999ac2ca752 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f9328589a94ded85fcbba10b02de525 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcc2de80fa5ef05855351153c8dd97dd |
| publicationDate | 1998-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0882699-A1 |
| titleOfInvention | Amino compounds and angiotensin iv receptor agonists |
| abstract | The present invention provides an aminoncompound represented by Formula:n nwherein X is CH 2 NH or CONH, Y is CH 2 NH or CONH with thenproviso that X and Y are not CONH at the same time; Z isnCH=C(R 4 )R 5 , CH 2 CH(R 4 )R 5 or an alkoxycarbonyl group, R 1 is anhydrogen atom; a lower alkyl group, a cycloalkyl group, ancycloalkyl-substituted alkyl group, an aralkyl group ornan aryl group, each group of which is substituted ornunsubstituted, R 2 and R 3 are each independently a lowernalkyl group or an aralkyl group, each group of which isnsubstituted or unsubstituted, and R 4 and R 5 are eachnindependently a hydrogen atom; an alkyl group, an aralkylngroup, an aryl group or a heteroaryl group, each group ofnwhich is substituted or unsubstituted, or anpharmaceutically acceptable salt thereof; a medicinencomprising the amino compound of Formula (1) or anpharmaceutically acceptable salt; and an angiotensin IVnreceptor agonist containing the same as an effectivencomponent, which are useful, in particular, as antherapeutical drug (antagonist or agonist) for variousndiseases in which angiotensin IV participates, fornexample, acceleration of renal blood flow, cerebral nvasodilation, inhibition of cell proliferation andnhypermnesia. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03011304-A1 |
| priorityDate | 1996-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 680.